|Articles|March 17, 2023
Your Ultimate Guide to Cell & Gene Therapy
Author(s)Eurofins
Eurofins BioPharma Product Testing supports the development of cell and gene therapies by providing comprehensive GMP-compliant CMC testing support to ensure the identity, potency, purity, and safety of starting materials, intermediate products, vectors, and final drug products as well as support for manufacturing process development and validation.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
